Back to Search
HORATIO DAUB, MD
MD
Family Medicine Physician
NPI: 1558345991Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
25MA04087000(NJ)
Research & Publications (20)
Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.
PMID 19651622·Mol Cell Proteomics·2009
8-other
Quantitative phosphokinome analysis of the Met pathway activated by the invasin internalin B from Listeria monocytogenes.
PMID 19640851·Mol Cell Proteomics·2009
8-other
Large-scale proteomics analysis of the human kinome.
PMID 19369195·Mol Cell Proteomics·2009
7-preclinical
Quantitative phosphoproteomics--an emerging key technology in signal-transduction research.
PMID 18837465·Proteomics·2008
6-review
Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.
PMID 18691976·Mol Cell·2008
8-other
Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics.
PMID 18515860·Mol Cell Proteomics·2008
7-preclinical
AXL is a potential target for therapeutic intervention in breast cancer progression.
PMID 18339872·Cancer Res·2008
8-other
Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry.
PMID 17192257·Mol Cell Proteomics·2007
8-other
Characterisation of kinase-selective inhibitors by chemical proteomics.
PMID 16198161·Biochim Biophys Acta·2005
6-review
Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling.
PMID 16061676·Cancer Res·2005
7-preclinical
Host cell targets in HCV therapy: novel strategy or proven practice?
PMID 15889531·Antivir Chem Chemother·2005
6-review
Strategies to overcome resistance to targeted protein kinase inhibitors.
PMID 15573099·Nat Rev Drug Discov·2004
6-review
Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitors.
PMID 15475568·Mol Cell Proteomics·2004
7-preclinical
Evaluation of kinase inhibitor selectivity by chemical proteomics.
PMID 15165517·Assay Drug Dev Technol·2004
6-review
Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors.
PMID 15157880·Chem Biol·2004
7-preclinical
Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors.
PMID 14769951·Mol Cell Proteomics·2004
7-preclinical
Proteomic analysis of kinase inhibitor selectivity and function.
PMID 14752275·Cell Cycle·2004
7-preclinical
An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.
PMID 14668439·Proc Natl Acad Sci U S A·2003
7-preclinical
Exploiting features of adenovirus replication to support mammalian kinase production.
PMID 14576328·Nucleic Acids Res·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1636 ROUTE 38 & EAYRESTOWN ROAD
LUMBERTON, NJ 08048 - Phone
- (609) 914-8440
Quick Facts
- NPI
- 1558345991
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile